1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders
(
- Contribution to journal › Article
-
Mark
Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease
(
- Contribution to journal › Article
- 2021
-
Mark
High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young
(
- Contribution to journal › Article
- 2020
-
Mark
Hereditary hypertrophic cardiomyopathy in children and young adults—The value of reevaluating and expanding gene panel analyses
(
- Contribution to journal › Article
-
Mark
Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant
(
- Contribution to journal › Article
-
Mark
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
(
- Contribution to journal › Article
- 2017
-
Mark
Assessing the GeneRead SNP panel for analysis of low-template and PCR-inhibitory samples
(
- Contribution to journal › Article
- 2016
-
Mark
In vivo CYP3A activity and pharmacokinetics of imatinib in relation to therapeutic outcome in chronic myeloid leukemia patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
(
- Contribution to journal › Article